Michael Bernard, MD, PhD
- Sr Physician, Southshore Region
- 1514 Jefferson Hwy, New Orleans, LA, 70121
For additional information or to make an appointment, click here.
Overview
Overview
- Dr. Michael Bernard graduated from Emory University in 1997 with degrees in biology and chemistry. He earned his joint medical and graduate degree from the Medical University of South Carolina in Charleston South Carolina in 2005. He completed a residency in internal medicine at Vanderbilt University Medical Center in 2008. He returned to the Medical University of South Carolina for a cardiology and electrophysiology fellowship which he finished in December 2012.Dr. Bernard has a particular interest in the treatment of cardiac arrhythmias and has extensive experience with complex catheter ablations. His clinical interests include cardiac device implantation and monitoring as well as treatment of cardiac arrhythmias. Research interests include oral anticoagulant strategies for cardiac device implantation and complex ablation procedures. During his graduate and post-graduate training, Dr. Bernard authored or contributed to over 15 peer-reviewed publications.
Publications
Selected publications
-
2023Risk of ventricular arrhythmias following implantable cardioverter-defibrillator generator change in patients with recovered ejection fraction: Implications for shared decision-making. Journal of Cardiovascular Electrophysiology.
-
2022Contact force catheter ablation for the treatment of persistent atrial fibrillation: Results from the PERSIST-END study. Journal of Cardiovascular Electrophysiology.
-
2022Watchman FLX Implantation for Challenging Left Atrial Appendage Anatomy: Case-Based Discussion. Current Problems in Cardiology. 47.
-
2022Performance and acute procedural outcomes of the EnSite Precision (TM) cardiac mapping system for electrophysiology mapping and ablation procedures: results from the EnSite Precision (TM) observational study. Journal of Interventional Cardiac Electrophysiology.
-
2021Common settings and workflows incorporating dynamic mapping software using a high-density grid mapping catheter. Journal of Cardiovascular Electrophysiology. 32:1488-1489.
-
2021Epidemiology, evaluation, and management of conduction disturbances after transcatheter aortic valve replacement. Progress in Cardiovascular Diseases. 66:37-45.
-
2021Initial experience of novel dynamic mapping software using a high-density grid mapping catheter in the United States. Journal of Cardiovascular Electrophysiology. 32:1488-1488.
-
2021The effect of dynamic mapping data on procedure efficiency in radiofrequency ablation of patients with atrial fibrillation. Journal of Cardiovascular Electrophysiology. 32:1490-1491.
-
2021The role of atrial fibrillation catheter ablation in patients with heart failure. Progress in Cardiovascular Diseases. 66:80-85.
-
2020Cardiac Computed Tomography for Atrial Fibrillation Patients Undergoing Ablation Implications for the Prediction of Early Recurrence. Journal of Thoracic Imaging. 35:186-192.
-
2020Class 1C antiarrhythmic drugs in atrial fibrillation and coronary artery disease. Journal of Cardiovascular Electrophysiology. 31:607-611.
-
2020In reply: Impaired myocardial blood flow in atrial fibrillation. Journal of Cardiovascular Electrophysiology. 31:1883-1883.
-
2020Left Atrial Posterior Wall Thrombus After Posterior Wall Ablation. The Ochsner Journal. 20:209-214.
-
2020Positron emission tomography absolute stress myocardial blood flow for risk stratification in nonischemic cardiomyopathy. Journal of Cardiovascular Electrophysiology. 31:1137-1146.
-
2020THE MAZE PROCEDURE IS A RISK FACTOR FOR LEFT ATRIAL THROMBUS. Journal of the American College of Cardiology. 75:374-374.
-
2020Utility of serial measurement of biomarkers of cardiovascular stress and inflammation in systolic dysfunction. EP-Europace. 22:1044-1053.
-
2019In reply-Atrial Fibrillation and Morbidity and Mortality in Stress-Induced Cardiomyopathy. Mayo Clinic Proceedings. 94:2148-2149.
-
2019Refractory Ventricular Tachycardia From Coronary Vasospasm During Pregnancy. The Ochsner Journal. 19:401-404.
-
2018Optimalmethod ofmeasuring the T-peak to T-end interval for risk stratification in primary prevention. EP-Europace. 20:698-705.
-
2018REFRACTORY VENTRICULAR TACHYCARDIA FROM CORONARY VASOSPASM IN PREGNANCY. Journal of the American College of Cardiology. 71:2187-2187.
-
2017In Reply-Atrial Fibrillation: Interatrial Block May Be an Underdiagnosed and Easily Recognizable Risk Factor. Mayo Clinic Proceedings. 92:682-682.
-
2017REDUCED FLOW CAPACITY AS MEASURED BY CARDIAC POSITRON EMISSION TOMOGRAPHY PREDICTS VENTRICULAR TACHYARRHYTHMIA IN PATIENTS WITH AN ICD. Journal of the American College of Cardiology. 69:1607-1607.
-
2017Time-varying circulating biomarkers predict ventricular tachyarrhythmia and death: the LIFEMARKER-VT study. European Heart Journal. 38:1377-1377.
-
2016Pacing Without Wires: Leadless Cardiac Pacing. The Ochsner Journal. 16:238-242.
-
2016The State of the Art: Atrial Fibrillation Epidemiology, Prevention, and Treatment. Mayo Clinic Proceedings. 91:1778-1810.
-
2015INCIDENCE OF PACEMAKER IMPLANTATION AND PARAVALVULAR AORTIC INSUFFICIENCY AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT: A COMPARISON OF THREE GENERATIONS OF EDWARDS SAPIEN VALVES. Journal of the American College of Cardiology. 65:A2034-A2034.
-
2015POSITRON EMISSION TOMOGRAPHY STRESS MYOCARDIAL BLOOD FLOW PREDICTS VENTRICULAR TACHYARRHYTHMIA IN PATIENTS WITH AN IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR. Journal of the American College of Cardiology. 65:A1149-A1149.
-
2014CORRELATION BETWEEN POSITRON EMISSION TOMOGRAPHY STRESS MYOCARDIAL BLOOD FLOW AND VENTRICULAR TACHYARRHYTHMIA OR DEATH IN PATIENTS WITH CARDIOMYOPATHY. Journal of the American College of Cardiology. 63:A293-A293.
-
2014Comparison of Atrial Fibrillation Ablation Bleeding and Thrombotic Complications with Dabigatran, Rivaroxaban and Warfarin. Journal of Cardiovascular Electrophysiology. 25:572-572.
